Valuation: Abbott Laboratories

Market Cap 202B 173B 162B 148B 279B 19,247B 282B 1,912B 744B 9,710B 758B 742B 32,157B P/E 2026 *
33.5x
P/E 2027 * 25.8x
Enterprise Value 226B 194B 181B 166B 313B 21,529B 316B 2,139B 833B 10,862B 848B 829B 35,970B EV / Sales 2026 *
4.49x
EV / Sales 2027 * 4.08x
Free-Float
86.16%
Yield 2026 *
2.2%
Yield 2027 * 2.35%
1 day+4.93%
1 week+1.61%
Current month+5.63%
1 month+8.57%
3 months+25.55%
6 months-16.13%
Current year-16.13%
1 week 110.37
Extreme 110.37
110.37
1 month 101.66
Extreme 101.66
110.37
Current year 82.56
Extreme 82.56
131.6
1 year 82.56
Extreme 82.56
131.6
3 years 82.56
Extreme 82.56
131.6
5 years 82.56
Extreme 82.56
131.6
10 years 82.56
Extreme 82.56
131.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+4.93%+1.61% - - 202B
-0.46%+5.22%-12.41%+11.93% 202B
-1.89%+0.60%-1.69%+12.44% 119B
+1.33%+4.97%+12.12%+83.51% 61.78B
+0.40%-5.32%+30.83%+55.98% 52.35B
-0.50%+4.22%-4.95%-31.49% 51.96B
-2.09%+0.45%+8.39%-11.71% 34.36B
+2.71%+2.18% - - 30.44B
-1.37%+0.54%+40.60%-11.04% 24.87B
+0.04%-0.90%-5.19%+24.89% 24.07B
Average +0.39%+1.45%+8.46%+16.81% 66.74B
Weighted average by Cap. +0.97%+2.83%+1.00%+18.00%

Financials

2026 *2027 *
Net sales 50.3B 43.1B 40.39B 36.89B 69.63B 4,796B 70.31B 476B 185B 2,419B 189B 185B 8,012B 54.65B 46.83B 43.88B 40.08B 75.64B 5,210B 76.38B 518B 201B 2,628B 205B 201B 8,704B
Net income 6.23B 5.34B 5B 4.57B 8.63B 594B 8.71B 59.03B 22.98B 300B 23.4B 22.89B 993B 7.92B 6.79B 6.36B 5.81B 10.97B 755B 11.08B 75.05B 29.22B 381B 29.75B 29.11B 1,262B
Net Debt 23.94B 20.51B 19.22B 17.56B 33.14B 2,282B 33.46B 227B 88.26B 1,151B 89.89B 87.93B 3,813B 20.96B 17.96B 16.83B 15.37B 29.01B 1,998B 29.29B 198B 77.27B 1,008B 78.69B 76.98B 3,338B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
24/08/26 $110.37 0.00%
21/08/26 $110.37 0.00%
20/08/26 $110.37 0.00%
19/08/26 $110.37 0.00%
18/08/26 $110.37 +1.61%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.67USD
Average target price
120.20USD
Spread / Average Target
+3.03%

Quarterly revenue - Rate of surprise